Back to Search
Start Over
Antipsychotic dose reduction: unclear benefits but certain risks.
- Source :
-
The lancet. Psychiatry [Lancet Psychiatry] 2023 Nov; Vol. 10 (11), pp. 819-821. Date of Electronic Publication: 2023 Sep 28. - Publication Year :
- 2023
-
Abstract
- Competing Interests: This work was supported by the Deutsches Zentrum für Psychische Gesundheit (German Center for Mental Health [grant: 01EE2303B]). SL has received honoraria as advisor or for lectures or educational material from Alkermes, Angelini, Apsen, Eisai, Gedeon Richter, Janssen, Karuna, Kynexis, Lundbeck, Medichem, Medscape, Merck Sharp and Dohme, Mitshubishi, Neurotorium, NovoNordisk, Otsuka, Recordati, Roche, Rovi, Sanofi Aventis, and TEVA. All other authors declare no competing interests.
Details
- Language :
- English
- ISSN :
- 2215-0374
- Volume :
- 10
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- The lancet. Psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 37778354
- Full Text :
- https://doi.org/10.1016/S2215-0366(23)00308-5